Phocas Financial’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-43,030
Closed -$3.23M – 65
2026
Q2
$3.23M Buy
+43,030
New +$2.76M 0.45% 99

Other funds holding HAE

Phocas Financial's HAE Position: Q3 2026 in Review

Phocas Financial sold out of Haemonetics (HAE) in Q3 2026, closing a stake of 43,030 shares — an estimated $3.23M sold.

Phocas Financial first reported a position in HAE in Q2 2026 and held it in 1 quarter. The position peaked at $3.23M in Q2 2026. 269 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • Phocas Financial reported no remaining Haemonetics position as of Q3 2026 after selling out during the quarter.
  • Phocas Financial sold 43,030 Haemonetics shares in Q3 2026, an estimated $3.23M.
  • Phocas Financial first reported a position in Haemonetics in Q2 2026 and held it in 1 quarter.
  • Phocas Financial's Haemonetics position peaked at $3.23M in Q2 2026.
  • 269 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on Phocas Financial's 13F filing for Q3 2026.